PL2898100T3 - Nieinwazyjny sposób określania metylomu płodu lub guza z wykorzystaniem osocza - Google Patents

Nieinwazyjny sposób określania metylomu płodu lub guza z wykorzystaniem osocza

Info

Publication number
PL2898100T3
PL2898100T3 PL13838770T PL13838770T PL2898100T3 PL 2898100 T3 PL2898100 T3 PL 2898100T3 PL 13838770 T PL13838770 T PL 13838770T PL 13838770 T PL13838770 T PL 13838770T PL 2898100 T3 PL2898100 T3 PL 2898100T3
Authority
PL
Poland
Prior art keywords
methyloma
fette
tumor
plasma
determining
Prior art date
Application number
PL13838770T
Other languages
English (en)
Other versions
PL2898100T5 (pl
Inventor
Rossa Wai Kwun Chiu
Kwan Chee Chan
Yuk-Ming Dennis Lo
Miu Fan Lun
Peiyong Jiang
Wai Man Chan
Original Assignee
The Chinese University Of Hong Kong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2898100(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by The Chinese University Of Hong Kong filed Critical The Chinese University Of Hong Kong
Publication of PL2898100T3 publication Critical patent/PL2898100T3/pl
Publication of PL2898100T5 publication Critical patent/PL2898100T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
PL13838770.9T 2012-09-20 2013-09-20 Nieinwazyjny sposób określania metylomu płodu lub guza z wykorzystaniem osocza PL2898100T5 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
PCT/AU2013/001088 WO2014043763A1 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of fetus or tumor from plasma
EP13838770.9A EP2898100B9 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of fetus or tumor from plasma

Publications (2)

Publication Number Publication Date
PL2898100T3 true PL2898100T3 (pl) 2018-06-29
PL2898100T5 PL2898100T5 (pl) 2023-11-06

Family

ID=50340462

Family Applications (5)

Application Number Title Priority Date Filing Date
PL17202149T PL3354747T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
PL19171630.7T PL3536807T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
PL24153604.4T PL4335929T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza w osoczu
PL22171427.2T PL4056712T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza w osoczu
PL13838770.9T PL2898100T5 (pl) 2012-09-20 2013-09-20 Nieinwazyjny sposób określania metylomu płodu lub guza z wykorzystaniem osocza

Family Applications Before (4)

Application Number Title Priority Date Filing Date
PL17202149T PL3354747T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
PL19171630.7T PL3536807T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
PL24153604.4T PL4335929T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza w osoczu
PL22171427.2T PL4056712T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza w osoczu

Country Status (28)

Country Link
EP (6) EP3839065A1 (pl)
JP (6) JP6317354B2 (pl)
KR (5) KR20230145530A (pl)
CN (2) CN117757932A (pl)
AU (5) AU2013317708C1 (pl)
BR (3) BR112015006183B1 (pl)
CA (2) CA3122779A1 (pl)
CY (1) CY1124139T1 (pl)
DK (4) DK4056712T3 (pl)
EA (1) EA201500327A1 (pl)
ES (5) ES2665273T5 (pl)
FI (2) FI3536807T3 (pl)
HR (3) HRP20240210T1 (pl)
HU (3) HUE053822T2 (pl)
IL (4) IL313451A (pl)
LT (2) LT4056712T (pl)
MX (1) MX360034B (pl)
MY (2) MY187444A (pl)
NZ (2) NZ717423A (pl)
PH (2) PH12022552061A1 (pl)
PL (5) PL3354747T3 (pl)
PT (4) PT4056712T (pl)
SG (2) SG10201705198UA (pl)
SI (1) SI4056712T1 (pl)
SM (1) SMT202100256T1 (pl)
TW (6) TWI806621B (pl)
WO (1) WO2014043763A1 (pl)
ZA (1) ZA201501772B (pl)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
PL3354747T3 (pl) * 2012-09-20 2021-07-26 The Chinese University Of Hong Kong Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3029148B1 (en) * 2013-07-30 2018-06-27 BGI Genomics Co., Limited Method for determining nucleic acid composition of nucleic acid mixture
US10174375B2 (en) 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
WO2015126840A1 (en) * 2014-02-18 2015-08-27 Bionano Genomics, Inc. Improved methods of determining nucleic acid structural information
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
CN113774132A (zh) * 2014-04-21 2021-12-10 纳特拉公司 检测染色体片段中的突变和倍性
US10801067B2 (en) 2014-05-09 2020-10-13 Eurofins Lifecodexx Gmbh Detection of DNA that originates from a specific cell-type and related methods
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
TWI895765B (zh) 2014-07-18 2025-09-01 香港中文大學 Dna混合物中之組織甲基化模式分析
CA2956208C (en) 2014-07-25 2025-07-08 University Of Washington METHODS FOR DETERMINING TISSUES AND/OR CELL TYPES RENDERING CELL-FREE DNA AND RELATED METHODS FOR DETERMINING A DISEASE OR DISORDER
PL4574996T3 (pl) * 2014-12-31 2026-03-02 Guardant Health, Inc. Wykrywanie i leczenie chorób wykazujących heterogeniczność komórek chorobowych oraz systemy i sposoby przekazywania wyników testów
US10364467B2 (en) * 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
SG11201706529TA (en) 2015-02-10 2017-09-28 Univ Hong Kong Chinese Detecting mutations for cancer screening and fetal analysis
DK3739061T3 (da) * 2015-07-20 2022-04-19 Univ Hong Kong Chinese Methyleringsmønsteranalyse af haplotyper i væv i DNA-blanding
US10453556B2 (en) * 2015-07-23 2019-10-22 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free DNA
CA2995422A1 (en) 2015-08-12 2017-02-16 The Chinese University Of Hong Kong Single-molecule sequencing of plasma dna
WO2017050244A1 (en) 2015-09-22 2017-03-30 The Chinese University Of Hong Kong Accurate quantification of fetal dna fraction by shallow-depth sequencing of maternal plasma dna
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
US20180327825A1 (en) * 2015-11-09 2018-11-15 Progenity, Inc. Methods for determining the origin of dna molecules
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
CN109072300B (zh) * 2015-12-17 2023-01-31 伊路敏纳公司 区分复杂生物样品中的甲基化水平
WO2017136603A1 (en) * 2016-02-02 2017-08-10 Guardant Health, Inc. Cancer evolution detection and diagnostic
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
WO2017181146A1 (en) * 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
JP6979554B2 (ja) * 2016-05-03 2021-12-15 ユニバーシティー ヘルス ネットワーク 無細胞メチル化ｄｎａを捕捉する方法及びその使用
CA3023335A1 (en) 2016-05-04 2017-11-30 Queen's University At Kingston Cell-free detection of methylated tumour dna
CN115161390B (zh) * 2016-05-30 2025-12-05 香港中文大学 使用血液中的无细胞dna检测血液病症
AU2017285496B2 (en) * 2016-06-16 2023-02-23 The Johns Hopkins University Methods and system for epigenetic analysis
CN107779485B (zh) 2016-08-24 2022-03-18 中国科学院分子细胞科学卓越创新中心 Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用
EP4209598A1 (en) 2016-10-19 2023-07-12 The Chinese University of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
CA3041647A1 (en) 2016-10-24 2018-05-03 The Chinese University Of Hong Kong Methods and systems for tumor detection
CA3039685A1 (en) * 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
ES2983411T3 (es) * 2016-12-13 2024-10-23 Bellwether Bio Inc Determinación de un estado fisiológico en un individuo analizando los puntos finales de fragmentos de ADN libre de células en una muestra biológica
BR112019014208A2 (pt) * 2017-01-11 2020-03-17 Quest Diagnostics Investments Llc Métodos para detectar diagnóstico falso-positivo de aneuploidia cromossômica em um feto e para detectar diagnóstico aneuploidiadiagnóstico de aneuploidia cromossômica falso-positiva em um feto.
RS65618B1 (sr) * 2017-01-24 2024-07-31 Bgi Genomics Co Ltd Postupak za utvrđivanje frakcije nukleinskih kiselina bez ćelija iz prethodno određenog izvora u biološkom uzorku
ES2990117T3 (es) 2017-01-25 2024-11-28 Univ Hong Kong Chinese Aplicaciones de diagnóstico que utilizan fragmentos de ácido nucleico
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
US12195802B2 (en) 2017-05-12 2025-01-14 President And Fellows Of Harvard College Universal early cancer diagnostics
KR102906417B1 (ko) * 2017-07-12 2025-12-30 에이엔디이 코포레이션 패턴 인식 시스템
BR112020000681A2 (pt) * 2017-07-12 2020-07-14 University Health Network detecção e classificação de cancro utilizando análise de metilome
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
ES2959360T3 (es) 2017-07-26 2024-02-23 Univ Hong Kong Chinese Mejora del cribado del cáncer mediante ácidos nucleicos víricos acelulares
WO2019055819A1 (en) 2017-09-14 2019-03-21 Grail, Inc. METHODS FOR PREPARING A SEQUENCING LIBRARY FROM SINGLE STRANDED DNA
EP4269583B1 (en) 2017-09-28 2025-12-31 Grail, Inc. ENRICHEMENT OF SHORT NUCLEIC ACID FRAGMENTS IN SEQUENCING BANK PREPARATION
US11168356B2 (en) 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
EP3765637A1 (en) 2018-03-13 2021-01-20 Grail, Inc. Anomalous fragment detection and classification
WO2019178496A1 (en) * 2018-03-15 2019-09-19 Grail, Inc. Tissue-specific methylation marker
AU2019249422B2 (en) * 2018-04-02 2025-09-25 Grail, Inc. Methylation markers and targeted methylation probe panels
CA3095056A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
US20210104297A1 (en) * 2018-04-16 2021-04-08 Grail, Inc. Systems and methods for determining tumor fraction in cell-free nucleic acid
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
IL281741B2 (en) 2018-09-27 2026-04-01 Grail Inc Methylation markers and a targeted methylation detection panel
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
EP4644568A3 (en) 2018-11-21 2025-12-03 Agilent Technologies, Inc. Methods for targeted nucleic acid library formation
TW202536188A (zh) * 2018-12-19 2025-09-16 香港中文大學 游離dna末端特徵
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
EP3921445B1 (en) 2019-02-05 2024-09-04 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
US12098429B2 (en) 2019-03-25 2024-09-24 The Chinese University Of Hong Kong Determining linear and circular forms of circulating nucleic acids
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
CA3135726A1 (en) * 2019-05-03 2020-11-12 Francis Barany Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
WO2021034034A1 (ko) * 2019-08-19 2021-02-25 주식회사 녹십자지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
AU2020391488A1 (en) * 2019-11-27 2022-06-09 Grail, Inc. Systems and methods for evaluating longitudinal biological feature data
CN115103909A (zh) 2020-01-31 2022-09-23 艾维达生物医学公司 用于靶向核酸捕获的系统和方法
KR20220148196A (ko) * 2020-02-10 2022-11-04 팔로젠 인코포레이티드 나노포어 디바이스 및 이를 사용하여 하전된 입자들을 검출하고 분류하는 방법
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
AU2021228737A1 (en) * 2020-02-28 2022-09-22 Grail, LLC. Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
CA3202240A1 (en) * 2020-11-19 2022-05-27 Nucleix Ltd. Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencing
JP2024500872A (ja) * 2020-12-17 2024-01-10 プレジデント アンド フェローズ オブ ハーバード カレッジ 胚外メチル化ＣｐＧアイランドを用いたがん検出の方法
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
US20240371467A1 (en) * 2021-09-28 2024-11-07 Act Genomics (ip) Limited Methylation biomarker selection apparatuses and methods
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
CN118215743A (zh) * 2021-11-04 2024-06-18 通用诊断股份公司 用于制备用于基因测序的生物样品的系统和方法
GB2636509B (en) 2022-02-07 2026-02-18 Centre For Novostics Fragmentation for measuring methylation and disease
EP4482985A4 (en) * 2022-02-22 2026-01-21 Flagship Pioneering Innovations Vi Llc Intra-individual analysis to determine the presence of health problems
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
WO2024112893A1 (en) * 2022-11-23 2024-05-30 Foundation Medicine, Inc. Systems and methods for tracking personalized methylation biomarkers for the detection of disease
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN118737268A (zh) * 2023-05-04 2024-10-01 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒的数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) * 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
ES2253461T3 (es) † 2002-03-05 2006-06-01 Epigenomics Ag Procedimiento y dispositivo para la determinacion de la especificidad del tejido y del adn que flota libre en tejidos corporales.
EP1570081A4 (en) * 2002-11-19 2006-05-31 Amgen Inc AMPLIFIED GENES INVOLVED IN CANCER
US20060183128A1 (en) † 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
WO2005090607A1 (en) * 2004-03-08 2005-09-29 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
JP2008545418A (ja) 2005-05-27 2008-12-18 ジョン ウェイン キャンサー インスティチュート 癌の診断、予後診断、および治療のための遊離循環ｄｎａの使用
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) * 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
TWI335354B (en) * 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
HUE061020T2 (hu) 2007-07-23 2023-05-28 Univ Hong Kong Chinese Nukleinsav-szekvencia kiegyensúlyozatlanságának meghatározására
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
US20120208711A1 (en) * 2009-10-02 2012-08-16 Centre For Addiction And Mental Health Method for Analysis of DNA Methylation Profiles of Cell-Free Circulating DNA in Bodily Fluids
SMT202300034T1 (it) * 2009-11-05 2023-03-17 Sequenom Inc Analisi genomica fetale da un campione biologico materno
EA034241B1 (ru) 2009-11-06 2020-01-21 Те Чайниз Юниверсити Ов Гонконг Способ пренатальной диагностики дисбаланса последовательности
WO2011091046A1 (en) * 2010-01-19 2011-07-28 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
DK2529032T3 (en) * 2010-01-26 2017-05-01 Nipd Genetics Ltd METHODS AND COMPOSITIONS FOR NON-INVASIVE PRE-NATIONAL DIAGNOSTICATION OF Fetal ANEUPLOIDITIES
EP3699915A1 (en) † 2010-04-29 2020-08-26 The Regents of The University of California Pathway recognition algorithm using data integration on genomic models (paradigm)
GB201007944D0 (en) 2010-05-12 2010-06-30 Univ Aberystwyth Methods
DK2576832T3 (en) 2010-05-25 2016-06-20 Univ Johns Hopkins CONFIGURATIONS AND METHODS FOR DETECTION OF neoplasia
CN103069006A (zh) * 2010-07-23 2013-04-24 艾索特里克斯遗传实验室有限责任公司 区别表达的胚胎或母源基因组区的鉴定及其用途
MX382244B (es) * 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
SG10202008532PA (en) † 2010-11-30 2020-10-29 Univ Hong Kong Chinese Detection of genetic or molecular aberrations associated with cancer
PL3354747T3 (pl) * 2012-09-20 2021-07-26 The Chinese University Of Hong Kong Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza

Also Published As

Publication number Publication date
DK4056712T3 (da) 2024-08-26
CN104781422A (zh) 2015-07-15
EP3839065A1 (en) 2021-06-23
AU2017251832B2 (en) 2019-10-10
BR112015006183A2 (pt) 2017-07-04
TW202043483A (zh) 2020-12-01
LT4056712T (lt) 2024-09-10
HUE053822T2 (hu) 2021-07-28
JP6317354B2 (ja) 2018-04-25
PL3536807T3 (pl) 2024-05-06
ES3060911T3 (en) 2026-03-30
HRP20241142T1 (hr) 2024-11-22
KR102307424B1 (ko) 2021-09-29
MY173356A (en) 2020-01-21
HUE068129T2 (hu) 2024-12-28
HUE066054T2 (hu) 2024-07-28
JP6985753B2 (ja) 2021-12-22
IL237495A0 (en) 2015-04-30
AU2013317708C1 (en) 2017-11-23
HRP20210716T1 (hr) 2021-06-11
JP2015536639A (ja) 2015-12-24
CY1124139T1 (el) 2022-05-27
ES2969567T3 (es) 2024-05-21
JP2018121644A (ja) 2018-08-09
EP2898100B2 (en) 2023-05-10
EP2898100B9 (en) 2023-08-02
CA2884066C (en) 2021-08-10
AU2022201026B2 (en) 2025-04-03
KR20230145530A (ko) 2023-10-17
FI3536807T3 (fi) 2024-02-01
BR122021021823B1 (pt) 2023-04-25
TWI901957B (zh) 2025-10-21
HK1207124A1 (en) 2016-01-22
KR20210120124A (ko) 2021-10-06
EP4056712A1 (en) 2022-09-14
LT3354747T (lt) 2021-04-12
MX2015003571A (es) 2015-06-22
KR20220065034A (ko) 2022-05-19
EP3536807B1 (en) 2023-11-29
PH12015500547A1 (en) 2015-05-04
CN104781422B (zh) 2023-12-26
EP4335929B1 (en) 2026-01-21
MX360034B (es) 2018-10-19
KR102587176B1 (ko) 2023-10-06
IL268512A (en) 2019-09-26
AU2013317708A1 (en) 2015-04-09
EP2898100B1 (en) 2017-11-22
CN117757932A (zh) 2024-03-26
HK1206797A1 (en) 2016-01-15
SG10201705198UA (en) 2017-07-28
CA2884066A1 (en) 2014-03-27
TWI640634B (zh) 2018-11-11
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
ZA201501772B (en) 2016-10-26
EP4335929A3 (en) 2024-05-29
BR112015006183B1 (pt) 2022-04-26
KR102148547B1 (ko) 2020-08-26
TWI784258B (zh) 2022-11-21
KR20200085928A (ko) 2020-07-15
TW201418474A (zh) 2014-05-16
JP2025026936A (ja) 2025-02-26
EP2898100A1 (en) 2015-07-29
IL299444A (en) 2023-02-01
PL4056712T3 (pl) 2024-12-02
PL2898100T5 (pl) 2023-11-06
TW201907013A (zh) 2019-02-16
EA201500327A1 (ru) 2015-07-30
EP3354747B1 (en) 2021-02-17
IL313451A (en) 2024-08-01
TW202334438A (zh) 2023-09-01
ES2665273T3 (es) 2018-04-25
AU2013317708B2 (en) 2017-08-03
HRP20240210T1 (hr) 2024-05-10
AU2020200128A1 (en) 2020-01-30
SG11201501927VA (en) 2015-04-29
DK2898100T4 (da) 2023-07-24
EP4335929A2 (en) 2024-03-13
DK2898100T3 (en) 2018-02-26
TW202605158A (zh) 2026-02-01
PT2898100T (pt) 2018-02-26
PT3536807T (pt) 2024-02-01
EP4056712B1 (en) 2024-07-31
TWI806621B (zh) 2023-06-21
EP2898100A4 (en) 2016-05-11
TWI707953B (zh) 2020-10-21
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
EP3354747A1 (en) 2018-08-01
KR20150082228A (ko) 2015-07-15
ES2994426T3 (en) 2025-01-23
JP2024009833A (ja) 2024-01-23
JP2020108400A (ja) 2020-07-16
CA3122779A1 (en) 2014-03-27
MY187444A (en) 2021-09-22
NZ717423A (en) 2017-08-25
DK3536807T3 (da) 2024-02-05
BR122021021825B1 (pt) 2022-05-24
JP6683752B2 (ja) 2020-04-22
EP4335929C0 (en) 2026-01-21
ES2665273T5 (es) 2023-10-02
FI4056712T3 (fi) 2024-08-29
PL3354747T3 (pl) 2021-07-26
SI4056712T1 (sl) 2024-10-30
JP7594817B2 (ja) 2024-12-05
JP2022031753A (ja) 2022-02-22
IL299444B2 (en) 2024-11-01
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
SMT202100256T1 (it) 2021-05-07
PL4335929T3 (pl) 2026-04-07
WO2014043763A1 (en) 2014-03-27
AU2020200128B2 (en) 2021-11-18
IL237495B (en) 2019-09-26
ES2862726T3 (es) 2021-10-07
DK3354747T3 (da) 2021-04-19
TW202305145A (zh) 2023-02-01
HK1257868A1 (en) 2019-11-01
AU2022201026A1 (en) 2022-03-10
PH12015500547B1 (en) 2024-05-17
AU2025205087A1 (en) 2025-07-24
NZ706269A (en) 2016-08-26
AU2017251832A1 (en) 2017-11-16
IL268512B2 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
PL2898100T5 (pl) Nieinwazyjny sposób określania metylomu płodu lub guza z wykorzystaniem osocza
LT2885010T (lt) Tautopatijos gydymo būdai
HUE042654T2 (hu) Eljárás genetikai variációk nem-invazív megállapítására
HUE048876T2 (hu) Rákos megbetegedések kezelése
PL2739153T3 (pl) Leczenie raka sutka
CO6870035A2 (es) Nuevos derivados bicíclicos de dihidroquinolina-2-ona
EP2858500A4 (en) BRUTON TYROSINE KINASE HEMMER
CO6920296A2 (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
HUE047198T2 (hu) Fitokannabinoidok emlõrák kezelésére
GB201305171D0 (en) Measurement of tissue structures
EP2834739A4 (en) TRANSACTION DIAGNOSTICS BLOCK
BR112014013850A2 (pt) conjunto de prateleiras
CO6960555A2 (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
AR092198A1 (es) Derivados de pirazolopirimidinas
EP2801020A4 (en) MOVEMENT OF ANIMATIONS
PT3626270T (pt) Tratamento de doenças cardiovasculares
EP2876447A4 (en) METHOD FOR DETECTING CANCER
EP2909975A4 (en) DYNAMIC FUNCTIONAL PARTITIONING
EP2782579A4 (en) PYRAZINKINASEINHIBITOREN
EP2876446A4 (en) METHOD FOR DETECTING CANCER
FI20116329L (fi) Mittauskohteen mittaus
HRP20180670T1 (hr) Novi postupak dobivanja spojeva namijenjenih upotrebi u liječenju raka
EP2933248A4 (en) NOVEL RENIN INHIBITOR
EP2920756A4 (en) KNOW-YOUR-CUSTOMER (KYC) EXAM
IL234606B (en) Novel methods and composition for treatment of disease